X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
index medicus (38) 38
middle aged (37) 37
hematology (36) 36
male (35) 35
female (33) 33
adult (28) 28
aged (24) 24
transplantation (18) 18
life sciences (15) 15
adolescent (14) 14
immunology (14) 14
oncology (14) 14
retrospective studies (14) 14
chemotherapy (13) 13
france (13) 13
acute myeloid-leukemia (12) 12
cancer (11) 11
hematopoietic stem cell transplantation (11) 11
recurrence (11) 11
societies, medical (11) 11
treatment outcome (11) 11
young adult (11) 11
follow-up studies (10) 10
prognosis (10) 10
transplantation, homologous (10) 10
allografts (9) 9
disease-free survival (9) 9
hematology, oncology and palliative medicine (9) 9
risk factors (9) 9
stem cells (9) 9
survival (9) 9
transplantation conditioning - methods (9) 9
allogeneic stem cell transplantation (8) 8
bone-marrow-transplantation (8) 8
child (8) 8
leukemia (8) 8
survival rate (8) 8
acute myeloid leukemia (7) 7
aged, 80 and over (7) 7
analysis (7) 7
bone marrow (7) 7
flow cytometry (7) 7
hematopoietic stem cell transplantation - adverse effects (7) 7
hematopoietic stem cells (7) 7
human health and pathology (7) 7
mortality (7) 7
multivariate analysis (7) 7
myelodysplastic syndrome (7) 7
patients (7) 7
expression (6) 6
lymphoma (6) 6
lymphomas (6) 6
prospective studies (6) 6
survival analysis (6) 6
versus-host-disease (6) 6
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (5) 5
abridged index medicus (5) 5
autografts (5) 5
child, preschool (5) 5
guidelines (5) 5
health aspects (5) 5
hematopoietic stem cell transplantation - methods (5) 5
mds (5) 5
myelodysplastic syndromes - mortality (5) 5
rituximab (5) 5
stem cell transplantation (5) 5
stem-cell transplantation (5) 5
time factors (5) 5
trial (5) 5
unrelated donors (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
activation (4) 4
adults (4) 4
allogreffe (4) 4
apoptosis (4) 4
autologous transplantation (4) 4
azacitidine (4) 4
benzoquinones - pharmacology (4) 4
bone marrow transplantation (4) 4
bone-marrow (4) 4
cohort studies (4) 4
hematopoietic stem cell transplantation - standards (4) 4
hemic and lymphatic diseases (4) 4
hemopoiesis (4) 4
hsp90 (4) 4
hsp90 heat-shock proteins - metabolism (4) 4
infections (4) 4
lactams, macrocyclic - pharmacology (4) 4
leukemia, myeloid, acute - mortality (4) 4
leukemia, myeloid, acute - therapy (4) 4
lymphome (4) 4
marrow-transplantation (4) 4
medical prognosis (4) 4
medical research (4) 4
medicine (4) 4
medicine, experimental (4) 4
medicine, research & experimental (4) 4
myelodysplastic syndromes - pathology (4) 4
neutropenia (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CODOX-M/IVAC | CLEAVED-CELL LYMPHOMA | ACUTE-LYMPHOBLASTIC-LEUKEMIA | MULTIAGENT CHEMOTHERAPY | ADOLESCENTS | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | SURVIVAL RATE | PEDIATRIC-ONCOLOGY-SOCIETY | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2010, Volume 65, Issue 12, pp. 2628 - 2640
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4533 - 4540
Journal Article
Haematologica, ISSN 0390-6078, 08/2010, Volume 95, Issue 8, pp. 1350 - 1357
Journal Article
Journal of Infection, ISSN 0163-4453, 07/2019, Volume 79, Issue 1, pp. 36 - 42
to prospectively evaluate the incidence and the clinical relevance on hematopoietic reconstitution of HHV-6 infection in autologous hematopoietic stem cell... 
Thrombocytopenia | Early infection | Autologous stem cell transplantation | HHV-6 | Neutropenia | Life Sciences | Hematology | Human health and pathology
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4230 - 4230
Abstract Introduction Post-transplant lymphoproliferative disorders (PTLD) are a rare but severe complication occurring after organ transplantation as a result... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4637 - 4637
Abstract Introduction Renal impairment occurs in 20-30% of newly diagnosed multiple myeloma patients, requiring dialysis for up to 10% of patients.Recent... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3698 - 3698
Abstract Introduction Human Herpes Virus 6 (HHV-6) is an opportunistic and potentially life-threatening infectious agent frequently identified after allogeneic... 
Journal Article
Blood, ISSN 0006-4971, 02/2013, Volume 121, Issue 6, pp. 1059 - 1064
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2013, Volume 162, Issue 4, pp. 489 - 497
Summary In tumour lysis syndrome (TLS), metabolic alterations caused by the destruction of malignant cells manifest as laboratory abnormalities with (clinical... 
haemodialysis | acute kidney failure | haematologic malignancy | hyperphosphataemia | intensive care units | Intensive care units | Hyperphosphataemia | Acute kidney failure | Haemodialysis | Haematologic malignancy | BURKITT LYMPHOMA/LEUKEMIA | PREVENTION | ACUTE-RENAL-FAILURE | RECOMBINANT URATE OXIDASE | PREDICTIVE MODEL | ACUTE MYELOID-LEUKEMIA | CHEMOTHERAPY | CANCER-PATIENTS | HYPERURICEMIA | HEMATOLOGY | CRITICALLY-ILL PATIENTS | Fluid Therapy | Urate Oxidase - therapeutic use | Prevalence | Prospective Studies | Hematologic Neoplasms - mortality | Humans | Middle Aged | Tumor Lysis Syndrome - blood | Male | Renal Replacement Therapy - utilization | Tumor Lysis Syndrome - etiology | Tumor Lysis Syndrome - epidemiology | Adult | Female | Acute Kidney Injury - chemically induced | Hematologic Neoplasms - complications | Drug Therapy, Combination | Urate Oxidase - administration & dosage | Acute Kidney Injury - drug therapy | Comorbidity | Acute Kidney Injury - blood | Risk Factors | Proportional Hazards Models | Tumor Burden | Remission Induction | Disease-Free Survival | Allopurinol - therapeutic use | Bicarbonates - administration & dosage | Allopurinol - administration & dosage | Hyperphosphatemia - etiology | Biomarkers | Hematologic Neoplasms - drug therapy | Hyperphosphatemia - drug therapy | Acute Kidney Injury - therapy | Aged | Tumor Lysis Syndrome - drug therapy | Acute Kidney Injury - epidemiology
Journal Article